
Sign up to save your podcasts
Or


In Part 1 we looked at an early study of GLP1 drugs and muscle loss. Today we’ll look at two more recent studies, one for Eli Lilly’s drug tirzepatide and one for Novo Nordisk’s drug semaglutide.
By with Ragen Chastain4
1818 ratings
In Part 1 we looked at an early study of GLP1 drugs and muscle loss. Today we’ll look at two more recent studies, one for Eli Lilly’s drug tirzepatide and one for Novo Nordisk’s drug semaglutide.

91,139 Listeners

43,712 Listeners

3,066 Listeners

7,530 Listeners

14,934 Listeners

8,187 Listeners

16,757 Listeners

16,096 Listeners

41,594 Listeners

422 Listeners

20,020 Listeners

225 Listeners

705 Listeners

150 Listeners

146 Listeners